Clinical Trial

Effects of Rifaximin on Gut Microbiota and Emotion

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated December 20, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
A randomized, triple-blind, placebo-controlled study on the effect of rifaximin on psychobiological functions in healthy men.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-10-17; most recent amendment 2024-12-17.
Status change: Not Yet Recruiting → Recruiting 2023-03-27
Trial Details
NCT Number NCT05587036
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Conditions Healthy Volunteers, Stress, Fear
Enrollment 60 participants
Start Date 2023-02-02
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-12-20